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Visual cortical circuits show profound plasticity during early life and are later stabilized 
by molecular "brakes" limiting excessive circuit rewiring beyond a critical period. How 
the appearance of these factors is coordinated during the transition from development 
to adulthood remains unknown. We analyzed the role of miR-29a, a miRNA targeting 
factors involved in several important pathways for plastici ty such as extracellular 
matrix and chromatin regulation. We found that visual cortical miR-29a expression in 
the visual cortex dramatically increases with age, but it is not experience -dependent. 
Precocious high levels of miR-29a induced by targeted intracortical injections of a miR-
29a mimic blocked ocular dominance plasticity and caused an early appearance of 
perineuronal nets. Conversely, inhibition of miR-29a in adult mice using LNA 
antagomirs activated ocular dominance plasticity, reduced perineuronal net intensity 
and number, and changed their chemical composition restoring permissive low 
chondroitin 4-O-sulfation levels characteristic of juvenile mice. Activated adult 
plasticity had the typical functional and proteomic signature of juvenile plasticity. 
Transcriptomic and proteomic studies indicated that miR-29a manipulation regulates 
the expression of plasticity factors acting at different cellular levels, from chromatin 
regulation to synaptic organization and extracellular matrix remodeling. Intrigui ngly, 
the projection of miR-29a regulated gene dataset onto cell-specific transcriptomes 
revealed that parvalbumin-positive interneurons and oligodendrocytes were the most 
affected cells. Overall, miR29a is a master regulator of the age -dependent plasticity 


















Brain postnatal development is characterized by temporal windows of high plasticity 
called critical or sensitive periods. The cellular mechanisms delimiting critical periods 
(CPs) have been classically studied using the model of ocular dominance (OD) 
plasticity of the visual cortex. Historical thinking was that OD plasticity is passively 
reduced with age; however it is becoming clear that plasticity levels are set by the 
integrated action of age- and experience-dependent factors actively promoting or 
suppressing circuit plasticity (“plasticity brakes”) (Hensch and Quinlan 2018; Levelt 
and Hübener 2012). These factors can act at different cellular levels, from 
transcriptional and translational control to synaptic intracellular and extracellular 
environment. For instance, perineuronal nets (PNNs) enwrapping parvalbumin-
positive (PV+) neurons increase in number and density, and change their chemical 
composition, with age inhibiting OD plasticity in the adult visual cortex (Carulli et al. 
2010; Pizzorusso et al. 2002; Rowlands et al. 2018; Beurdeley et al. 2012; Miyata et 
al. 2012). Epigenetic factors such as histone acetylation and DNA methylation are also 
changed in coincidence with the closure of the critical period (CP) (Stroud et al. 2017; 
Tognini et al. 2015; Putignano et al. 2007), and their manipulation can reactivate 
juvenile-like plasticity in the adult (Putignano et al. 2007; Silingardi et al. 2010; Apulei 
et al. 2019). However, the mechanisms coordinating the expression of these plasticity 
mechanisms are totally unexplored. 
MicroRNAs (miRNAs) are small molecules of non-coding RNA that regulate their 
targets by repressing mRNA translation and reducing mRNA stability (Bartel 2018). 
Because each miRNA can target several transcripts, miRNAs can efficiently coordinate 
different cellular pathways acting as master regulators of complex biologically 
processes (Rajman and Schratt 2017; Lippi et al. 2016). We hypothesized that this 
property of miRNAs could also mediate the coordinated age-regulation of different 
plasticity mechanisms setting CP timing. Previous work showed that during postnatal 
development there is a dramatic change of mouse visual cortex transcriptome 
accompanied by conspicuous changes in miRNA expression (Mazziotti et al. 2017). In 
particular, the most upregulated miRNA was miR-29a-3p (miR-29a), a member of a 
family including miR-29a, b1, b2, and c. Mir-29 family is strongly regulated by age 
 




across different species and different tissues (Baumgart et al. 2012; Somel et al. 2010; 
Takahashi et al. 2012; Fenn et al. 2013; Nolan et al. 2014; Ugalde et al. 2011; Inukai 
et al. 2012). Its predicted targets are enriched in remodelling enzymes of extracellular 
matrix and epigenetic factors (Amodio et al. 2015; Fabbri et al. 2007; Foscarin et al. 
2017), two classes of molecules regulating the CP for OD plasticity. Thus, we studied 
whether miR-29a could act as an age-dependent regulator of plasticity in the visual 
cortex. 
Our results shows that miR-29a levels in the visual cortex are a critical determinant of 
plasticity acting on PNNs and epigenetic factors. Indeed, if miR-29a action is enhanced 
in juvenile mice, OD plasticity is blocked and PNNs are increased. Conversely 
antagonizing miR-29a in the adult promotes OD plasticity mechanisms sharing 
molecular and functional signature of juvenile plasticity. These effects are associated 
with the induction of plasticity factors acting on the chromatin epigenetic status and 
reestablishing immature PNNs. Thus, miR-29a is a master regulator of plasticity 





miR-29a age-dependent increase controls extracellular matrix and gene 
transcription regulating factors  
 
In order to unravel key miRNAs that regulate postnatal development of the visual 
cortex, we reanalyzed our dataset of coupled miRNA-seq and RNA-seq in the 
developing mouse visual cortex. This analysis compared two time points: postnatal 
day 10 (P10), immediately before eye opening and CP onset, and P28 when mouse 
cortex displays developed functional properties (Mazziotti et al. 2017). The miR-29 
family, and in particular miR-29a-3p, was the microRNA with the largest age-
dependent up-regulation. Importantly, we found a highly significant overrepresentation 
of miR-29a predicted targets among the genes downregulated with age (fig.1a, 1051 
predicted targets by Targetscan, 5429 genes downregulated with age; 554 genes in 
the intersection, odds ratio 4.40; Fisher exact test, p< 0.001), but not among age 
upregulated genes (fig.1b, 4339 upregulated genes with age; 164 genes in the 
 




intersection, odds ratio 0.93; Fisher exact test p=0.93). These data suggest that miR-
29a contributes to the age-dependent repression of gene expression by destabilization 
of its target transcripts. To gain insights into the molecular consequences of miR-29a 
upregulation with age, we performed a gene ontology analysis of miR-29a putative 
targets enriched in downregulated genes using the DAVID analysis (Huang et al. 2009; 
Huang et al. 2009). We found a significant overrepresentation in the categories 
“extracellular matrix organization” and “gene expression (transcription)”, including key 
genes such as MMPs and ADAMTS, and  Dnmt3a, Dnmt3b, TDG, Tet1, Tet2, and 
Tet3, respectively (fig.1c). Both pathways are well known to regulate OD plasticity of 
visual cortex during CP and  to promote plasticity in adult rodents after their 
manipulation (Carulli et al. 2010; Fawcett et al. 2019; Pizzorusso et al. 2006; 
Pizzorusso et al. 2002; Rowlands et al. 2018; Tognini et al. 2015; Apulei et al. 2019).  
To gain better temporal resolution of the age-dependent regulation of miR-29a 
expression in the visual cortex, we performed a RT-PCR analysis and observed a 
dramatic 30-fold increase in mir-29a levels beginning after P10 and reaching a plateau 
around P120, when OD plasticity is strongly reduced (fig.1d; n=3/4 for each age; one-
way ANOVA, p<0.0001; post hoc Tukey’s test: p10 vs p25, p35, p60, p120, p200 
p<0.0001; p25 vs p35, p60, p120, p200 p<0.0001;  p35 vs p60, p120, p200, p<0.0001; 
other tests not significant). In parallel, we analyzed the age-dependent expression of 
Dnmt3a, a canonical and well-validated target of miR-29 (Amodio et al. 2015; Morita 
et al. 2013; Kuc et al. 2017; Fabbri et al. 2007). Dnmt3a expression was strongly 
downregulated with age (fig.1e; n=3/4 for each age; one-way ANOVA, p<0.0001; post 
hoc Tukey’s test: p10 vs p25, p<0.0001; p10 vs p35, p<0.0001; p10 vs p60, p<0.0001; 
p10 vs p120, p<0.0001; p10 vs p200, p<0.0001; p25 vs p35, ns; p25 vs p60, ns; p25 
vs p120, p<0.01; p25 vs p200, p<0.0001;  p35 vs p60, p<0.0001; p35 vs p120, p<0.05; 
p35 vs p200, ns; p60 vs p120, ns; p60 vs p200, ns; p120 vs p200, ns), and, as shown 
in fig.1f, its levels were negatively correlated with miR-29a expression (Pearson 
correlation: r=-0.817, p<0.001). To investigate the distribution of miR-29a in visual 
cortical cells we performed in situ hybridization at P25 and P120 using LNA probes 
recognizing the mature miRNA. The results confirmed the strong age-dependent 
upregulation of miR-29a (fig.1g, N=3). Furthermore, at both ages the vast majority of 
cortical cells expressed miR-29a. Considering the importance of PV+ interneurons in 
 




CP regulation (Takesian and Hensch 2013; Levelt and Hübener 2012), we specifically 
assessed miR-29a expression in these cells by triple staining for miR-29a, PV, and a 
nuclear marker (fig.1h). We found that miR-29a was expressed in many, if not all, PV+ 
interneurons. 
Several molecular mediators of visual cortical plasticity, such as miR-132, Arc, Bdnf 
and Npas4, show experience-dependent expression (Tognini et al. 2015; Kim et al. 
2018; Klein et al. 2007; Tognini et al. 2011; Gao et al. 2010). Thus, we investigated 
the effects of sensory stimulation on miR-29a expression by  four different protocols of 
visual manipulation: i) dark rearing from birth (fig.2a; normal rearing (NR) (N=5) vs dark 
rearing (DR) (N=5); t-test, p=0.19); ii) DR from P10 (fig.2b; NR vs DR, N=4-5; t-test, 
p=0.70); iii) one week in darkness (P30-P37) followed by 4 h of light exposure (fig.2c; 
controls animals (ctr) vs one week of dark and no light re-exposure (0H) vs one week 
of dark and 4 hours of light re-exposure (4H), N=4 for each group; one-way ANOVA, 
p=0.68); and iv) 3 days of MD (P25-P28) (fig.2d; contralateral cortex (contra ctx) vs 
ipsilateral cortex (ipsi ctx) to deprived eye, N=9; paired t test, p=0.52). None of these 
manipulations affected miR-29a expression, indicating that expression of miR-29a is 
dictated by an intrinsic developmental timing that is not influenced by visual 
experience. 
Taken together, these results show that miR-29a expression in the visual cortex is 
strongly age-dependent and correlates with the plasticity reduction occurring at the 
end of the CP, naturally leading to the hypothesis that miR-29a is causally linked to 
the age-dependent regulation of experience-dependent plasticity in visual cortical 
circuits. 
 
Increasing miR-29a action during the CP blocks OD plasticity 
 
If our hypothesis is correct, a premature increase of miR-29a during CP should be 
sufficient to reduce plasticity mimicking CP closure. To test this possibility, we induced 
a miR-29a upregulation during CP through intracortical administration of a synthetic 
miR-29a mimic (mim29a) and tested for the presence of OD plasticity (fig.3a). P24 
mice were acutely injected with mim29a at three cortical sites surrounding the 
binocular visual cortex as identified by optical imaging of the intrinsic signal (IOS). 
Baseline visual responses were acquired 24h after injection and the eyelids of the eye 
 




contralateral to the treated cortex were sutured shut. A second injection was performed 
at P26 and OD assessment and molecular analyses were performed at P28. An 
oligonucleotide with a scrambled sequence matching miR-29a nucleotide composition 
was injected as control.  
To quantify the molecular efficacy of mim29a treatment, we measured the levels of 
miR-29a and of its validated target Dnmt3a at P28 (N=3) by RT-PCR. We detected 
nearly a doubling in miR-29a levels [fig.3b animals treated with scrambled mimic (scr) 
vs animals treated with miR-29a mimic  (mim29a); t-test  , p=0.005] and a 
corresponding significant decrease of Dnmt3a levels in the visual cortex treated with 
miR-29a mimic with respect to control-treated cortex (fig.3c scr vs mim29a t-test , 
p<0.0001). 
We then assessed OD plasticity by recording IOS elicited by stimulation of either eye 
twice: before monocular deprivation (MD) at P24 and at the end of the protocol (P28). 
In control-treated mice, MD resulted in a reduction of the IOS elicited by stimulation of 
the contralateral eye. In mice treated with mim29a,  this shift of OD was not observed 
(fig.3d; OD index (ODI) of scrambled treated mice (scr) (N=6) vs mim29a treated mice 
(mimic 29a) (N=8); two-way ANOVA RM, treatment X time, p= 0.029; post hoc Sidak’s 
comparison, pre-MD scr vs post-MD scr, p=0.0009; pre-MD  mimic 29a vs post-MD 
mimic 29a, p=0.21). The loss of plasticity induced by miR-29a mimic was confirmed 
by analysis of the molecular markers Npas4 and Bdnf exon IV. Expression of these 
activity-dependent transcripts is reduced by monocular deprivation (Tognini et al. 
2015). However, the amplitude of their down-regulation was smaller in miR-29a treated 
mice with respect to controls (fig.3e; scr vs mimic 29a; N=4; t-test, Npas4: p=0.038; 
Bdnf exIV:  p=0.049).  
Overall, these data demonstrate that precocious upregulation of miR-29a is sufficient 
to induce closure of the CP.  
 
MiR-29a antagonization in adult  mice promotes OD plasticity 
 
We then tested whether antagonization of miR-29a in the adult (P>120) visual cortex 
could enhance OD plasticity. To reduce miR-29a biological activity in the visual cortex, 
we injected a locked nucleic acid (LNA) sequence complementary to miR29a (amiR-
29a) or a control LNA oligonucleotide carrying a scrambled sequence. LNA 
 




oligonucleotides stably bind their complementary miRNA thereby blocking its activity; 
moreover they are resistant to enzymatic degradation and are approved for use in 
humans (Khvorova and Watts 2017; Braasch and Corey 2001; Smith et al. 2019) . 
Injections were performed at three sites surrounding the binocular visual cortex 
identified by IOS imaging. Molecular analyses were performed seven days after amiR-
29a injections (fig.4a).  
To assess the efficacy and the specificity of the amiR-29a treatment, we performed 
RT-PCR and RNA-seq analysis from the treated cortex. RT-PCR analysis revealed 
that amiR-29a treatment caused a decrease of mir-29a and an increase in the miR-
29a target Dnmt3a (fig.4b-c; scr vs amiR-29a; N=3; t-test,  miR-29a p=0.0010; Dnmt3a  
p=0.0019). RNA-seq detected expression of 15303 genes, out of which 1421 were 
differentially expressed genes (DEGs) between amiR-29a and control treated mice 
(q<0.05), with 985 showing up-regulation and 436 down-regulation (fig.4d; Suppl. table 
1). Importantly, upregulated genes were significantly enriched in miR29a targets, but 
not in targets of other miRNAs (miTEA-miRNA Target Enrichment Analysis, p<0.001)  
(Steinfeld et al. 2013; Eden et al. 2009). Moreover, 26% of the upregulated genes were 
also downregulated by age suggesting that miR-29a inhibition could reverse part of 
the age-dependent transcriptional regulation. To assess amiR-29a effects at protein 
level, we performed proteomic analysis by means mass-spectroscopy-based 
proteomics with tandem-mass-tag (TMT) multiplexing in an independent set of 
animals. First, hierarchical clustering analysis of samples based of protein abundance 
showed that animals treated with amiR-29a cluster together demonstrating that the 
treatment has a coherent effect on global protein composition in the treated mice 
(Suppl. fig. 1). Among the 4595 detected proteins, we found 360 proteins to be 
significantly upregulated and 338 proteins to be significantly downregulated (Suppl. 
table 2). The fold changes of differentially  expressed proteins and transcripts showed 
significant correlation (fig.4e, Spearman coefficient correlation, r=0.1218; p=0.008, 
suppl. table 3). Gene ontology analysis of positively correlated proteins and RNA 
performed with DAVID demonstrated an overrepresentation of extracellular matrix 
remodelers (fig.4f). Regulation of transcripts belonging to the two categories 
overrepresented among the predicted targets of miR-29a, i.e. extracellular matrix 
remodelers and epigenetic regulation of transcription, was also studied by RT-PCR. 
 




We found a significant increase in MMP2, MMP9 and MMP13 (fig.4g; scr vs amiR-29a; 
N=4/8; t-test, MMP2: p<0.0001; MMP9: p=0.0015; MMP13: p=0.0005) as well as in 
Dnmt3a, Tet3, Gadd45a and Gadd45b (fig.4g; scr vs miR-29a; N=4/8; unpaired t test, 
Dnmt3a: p<0.0001; Tet3: p=0.008; Gadd45a: p=0.015; Gadd45b: p=0.012). In 
addition, the increase in the canonical miR-29a target Dnmt3a was also confirmed by 
western blot (fig.4i, scr vs miR-29a; N=7; t-test, DNMT3a: p=0.008). Intriguingly, all 
these factors have also been involved in the regulation of OD plasticity (Tognini et al. 
2015; Apulei et al. 2019; Murase et al. 2017; Spolidoro et al. 2012; Kelly et al. 2015) , 
suggesting that the age-dependent increase of miR-29a could contribute to repress 
plasticity by a coordinated downregulation of these permissive factors. 
To get insights into cell specificity of amiR-29a effects, we projected regulated proteins 
on the cell clusters obtained by single-cell RNA seq of the adult mouse visual cortex 
(Tasic et al. 2016) (suppl. fig.2a) using the single cell portal for brain research launched 
by the Broad Institute of MIT. This approach visualizes the density of regulated proteins 
in the different cell subtypes. We observed an apparent enrichment of upregulated 
proteins in mature oligodendrocytes (suppl. fig.2b). This result is particularly interesting 
in light of the repressive role that myelin exerts on neuronal plasticity (McGee et al. 
2005). Intriguingly, the top cell type enriched in downregulated proteins was the CP 
regulator class of PV+ cells (suppl. fig.2c). A high sensitivity of PV+ cells to miR-29a 
antagonization was also confirmed by immunohistochemistry analysis of PV intensity 
(suppl. fig.2d). The results  show a shift in PV immunolabeling intensity towards low 
levels in the amiR-29a treated visual cortex treated (suppl. fig.2e), while PV+ cell 
density remained unaffected (suppl. fig.2f). This result suggests that miR-29a could be 
involved in maturation of PV cells and closure and the critical period. 
Thus, we next asked whether miR-29a inhibition could promote OD plasticity in the 
adult. Mice were injected with amiR-29a or control at P120, 3 days later MD of the eye 
contralateral to the treated cortex was performed. After 4 days molecular and 
functional assessment was performed (scheme in fig.4a). Functional studies were 
done assessing the cortical response to the visual stimulation of the deprived and the 
nondeprived eye by visual evoked potentials (VEPs) recordings and IOS imaging. 
VEPs showed a significant reduction of the ratio between the response to the deprived 
and the nondeprived eye in mouse treated with amiR-29a LNA, but not in controls 
 




(fig.5a; three groups of mice: non MD treated with saline (sal noMD), scramble treated 
MD (scr+MD), amiR29a treated MD (amiR-29a+MD) N=6/7; one-way ANOVA, 
p=0.0003; post hoc Tukey’s test: sal noMD vs scr+MD, ns; sal noMD vs amiR-
29a+MD, p=0.0002; scr+MD vs amiR-29a+MD, p=0.0169). IOS analysis confirmed the 
presence of OD plasticity in amiR-29a treated mice, but also extended these data 
showing that no difference in visual responses of amiR-29a and control mice were 
present before MD. AmiR-29a treated mice, but not control mice, showed a decline in 
the OD index after MD (fig.5b; ODI scr (N=5) vs amiR-29a (N=6), two-way ANOVA 
RM, treatment X time, p= 0.0074; post hoc Sidak’s test, pre-MD scr vs post-MD scr, 
ns; pre-MD vs post-MD amiR-29a, p=0.0005). Thus, both VEPs and IOS performed in 
separate cohorts of mice confirmed activation of OD  plasticity in adult mice by miR-
29a inhibition. 
 
Common functional and molecular signatures of MD during CP and after 
plasticity activation by miR-29a inhibition 
 
Previous work suggested that short MD durations in juvenile mice result in selective 
depression of deprived eye responses (Sato and Stryker 2008; Frenkel and Bear 
2004). Thus, we investigated whether this property is present also in the adult OD 
plasticity elicited by amiR-29a. Longitudinal assessment using IOS allows to analyze 
the absolute value of visual responses of each eye before and after MD. We found that 
MD significantly decreased the amplitude of visual responses of the deprived eye 
exclusively in amiR-29a treated mice but not in controls (fig.5c,d; amiR-29a (N=6) vs 
scr (N=5); two-way ANOVA RM, time X treatment interaction p=0.034; post hoc Sidak’s 
test; pre-MD vs post-MD scr, ns; pre-MD vs post-MD amiR-29a, p=0.0008). As 
expected, the response amplitude of the ipsilateral nondeprived eye did not change in 
amiR-29a or control groups (fig.5c,e; amiR-29a (N=6) vs scr (N=5); two-way ANOVA 
RM, time X treatment interaction, ns). 
Since amiR-29a induced plasticity shared functional characteristics with CP plasticity, 
we investigated whether plasticity induced in the adult visual cortex by miR-29a 
antagonization also displayed a molecular regulation typical of CP plasticity. We 
initially studied two activity-dependent genes (Npas4 and Bdnf exIV) strongly 
downregulated by MD during CP. We found that the effect of  MD on their expression 
 




was very pronounced in amiR-29a treated mice (fig.5f; scr vs amiR-29a; t-test; N=8-9, 
Npas4: p=0.035; N=4-5; Bdnf exIV:  p=0.026). To achieve a more complete 
comparison of the molecular signature of amiR-29a induced plasticity with CP 
plasticity, we performed proteomic analyses comparing the changes induced by MD in 
young CP mice and in adult mice treated with amiR-29a (Suppl tables 4-5). In CP mice 
2172 proteins were quantified. 168 proteins resulted to be significantly regulated by 
MD (p<0.05). The same analysis in adult mice treated with amiR-29a allowed the 
quantification of 1873 proteins, 199 of them significantly regulated by MD (p<0.05). To 
reveal whether a similar proteomic change was induced by MD in amiR-29a treated 
mice and in CP mice, we correlated the fold change expression induced by MD in the 
two datasets. All the measured proteins with a fold change>0.1 were included in the 
analysis. We found a positive correlation (fig.5g; Pearson correlation: r=0.193, 
p=0.019, Suppl. table 4) indicating a similar MD proteome signature in the two 
datasets. This protein group was further subdivided in two groups depending on 
showing correlation or anticorrelation between MD regulation during CP and after 
amiR-29a treatment. Then, we performed gene ontology analysis to characterize 
protein biological function. Due to the limited number of proteins we used the reactome 
platform.  Intriguingly, while no specific enrichment was observed for the proteins 
showing inconsistent MD regulation,  the proteins showing consisting MD regulation 
during CP and after adult treatment with amiR-29a were significantly enriched in 
categories such as CREB phosphorylation through the activation of CaMKII (R-MMU-
442729), unblocking of NMDA receptor (R-MMU-438006), transmission across 
chemical synapses (R-MMU-112315) known to be involved in OD plasticity (fig.5h). 
Moreover, we analyzed consistently MD regulated proteins  using SynGo,  a new 
database specific for proteins whose involvement in synaptic functions and plasticity 
is well established (Koopmans et al. 2019). The results demonstrated that correlated 
MD regulated proteins were highly significantly enriched in presynaptic and 
postsynaptic proteins mostly located on excitatory synapses. No enrichment was 
observed for anticorrelated proteins (fig.5i,j). A full list of the significant categories is 
shown in Suppl. table 5,6. Thus, the mechanisms underlying OD plasticity induced by 
miR-29a antagonization in the adult visual cortex activates molecular processes similar 
to those activated during CP plasticity. 
 





miR29a age-dependent expression regulates PNN structure and chemical 
composition 
 
In order to understand the mechanisms by which different levels of miR-29a in adult 
and CP mice affect OD plasticity, we investigated PNN formation after manipulation of 
miR-29a levels in the visual cortex of juvenile and adult mice. Indeed studies in rodents 
showed that PV+ cell PNN maturation in the visual cortex closes the CP for OD 
plasticity (Carulli et al. 2010; Fawcett et al. 2019; Pizzorusso et al. 2006; Pizzorusso 
et al. 2002; Rowlands et al. 2018; Beurdeley et al. 2012; Lensjø et al. 2017; Boggio et 
al. 2019). Moreover, in silico prediction and our experimental evidences showed that 
miR-29a targets are enriched in extracellular remodelling factors, and that the  PV+ 
cells show significant proteomic modulation by miR-29a (fig. 1c, fig. 4g, suppl. fig. 
2c,d). Thus, we revealed PNNs using Wisteria Floribunda Agglutinin (WFA) both in 
juvenile mice treated with miR-29a mimic and in adult mice treated with amiR-29a.  
We found that inducing the high miR-29a levels typical of the adult in the juvenile visual 
cortex by miR-29a mimic, resulted in enhanced PNN labelling (fig.6a-b, scr vs mim29a, 
N=3 mice per group; t-test, p=0.014), while no effects was observed on PNN density 
(fig.6a-c, scr vs mim29a, N=3 mice per group; t-test, p=0.20). Subdividing the 
distribution of PNN intensity in tertiles corresponding to strong, medium and faint 
PNNs, we observed a significantly higher fraction of strong PNNs in miR-29a mimic 
treated mice as compared to controls (fig.6 d-e; scr N=1438 cells vs mim29a N=1749 
cells, Kolmogorov-Smirnov test, p value< 0,0001). A high fraction of strongly labelled 
PNNs is typical of adult mice expressing low OD plasticity levels (Fawcett et al. 2019). 
Thus, premature high levels of miR-29a resulted in PNN early maturation and reduced 
plasticity levels.   
To test whether the age-dependent increase of miR-29a triggers PNN maturation and 
CP offset, we analysed PNNs in adult mice treated with amiR-29a. amiR-29a treatment 
resulted in a reduction in PNN intensity (fig. 6f-g; scr vs amiR-29a, N=3 mice per group; 
t-test, p=0.047) and density (fig. 6f-h; scr vs amiR-29a, N=3 mice per group; t-test, 
p=0.03), determining a lower fraction of strong PNNs (fig. 6i-j; scr N=1883 cells vs 
amiR-29a N=1937 cells, Kolmogorov-Smirnov test,  p< 0.0001). Age-dependent PNN 
maturation also involves changes in glycosaminoglycan (GAG) sulfation of chondroitin 
 




sulfate proteoglycans. Indeed, during PNN maturation there is a shift from GAG 
sulfation in 6 (C6S) position to sulfation in 4 (C4S) position. Previous work showed that 
restoring the juvenile form of GAG sulfation promotes plasticity in the adult visual 
cortex and renders CSPGs more permissive to axon growth, regeneration and 
plasticity (Miyata et al. 2012; Yang et al. 2017). Thus, we tested if amiR-29a could also 
affect mature PNNs also by reducing the adult C4S form of GAG sulfation. Biochemical 
analyses showed a significant decrease of C4S in adult animals treated with amiR-29a 
(fig. 6k; ng of C4S/ug normalized to untreated cortex for scr and amiR-29a mice; N=4-
5, unpaired t test, p=0.0008 ) suggesting a reduction of the inhibitory role of PNNs for 
plasticity. C4S decrease was associated with a highly significant increase of ArsB 
(Zhang et al. 2014; Yoo et al. 2013), an enzyme that catalyzes C4S removal and that 
has been suggested to be a target of miR-29 family including miR-29a (fig. 6l; N=4, scr 
vs amiR-29a treated cortex, unpaired t test, p=0.043). Thus, inducing in the adult visual 
cortex the low levels of miR-29a typical of juvenile mice promotes OD plasticity and 
restores PNN condensation and chemical composition typical of juvenile highly plastic 






Our work shows that miR-29a is a master age-dependent regulator of plasticity in the 
visual cortex. Indeed, we showed that manipulations of miR-29a action mimicking adult 
or juvenile levels of miR-29a correspondingly determine adult or juvenile levels of OD 
plasticity. Premature increase of miR-29a levels in young mice blocked juvenile OD 
plasticity while miR-29a downregulation in adult animals induced OD plasticity with the 
typical physiological and proteomic signature of juvenile plasticity. 
To deeply characterize the molecular underpinnings of miR-29a action on OD 
plasticity, we performed transcriptomic and proteomic analyses after amiR-29a 
treatment in adult mice. The results showed a remarkable convergence of  miR-29a 
action on plasticity brakes controlling plasticity levels by acting on different cell 
functions and compartments. For example, previous work showed that OD plasticity 
can be promoted in the visual cortex by inhibiting epigenetic enzymes decreasing 
histone acetylation such as HDACs, or activating DNA methylation regulatory 
 




pathways involving Gadd45b/g and Tets (Silingardi et al. 2010; Putignano et al. 2007; 
Apulei et al. 2019). Importantly, the results of these interventions restore the strong 
and highly malleable epigenetic control of chromatin typical of juvenile animals (Stroud 
et al. 2017; Tognini et al. 2015; Putignano et al. 2007; Baroncelli et al. 2016; Vierci et 
al. 2016). Our analysis shows that miR-29a levels are tightly correlated with Dnmt3a, 
and that manipulation of miR-29a levels dramatically affects Dnmt3a; Tet1,2 and 3; 
and Gadd45a and b. Moreover, antagonization of miR-29a also resulted in induction 
of Arc, a gene capable of activating OD plasticity in the adult  (Jenks et al. 2017; 
McCurry et al. 2010), and other plasticity factors such as Egr-1 and Egr-2, Nr4a1 and 
Nr4a2 (Mo et al. 2015; Chen et al. 2014; Knapska and Kaczmarek 2004;) . 
Furthermore, our work shows that miR-29a level in the visual cortex is a critical 
determinant of PNN maturation, another important plasticity brake in the visual cortex 
(Carulli et al. 2010; Pizzorusso et al. 2006; Pizzorusso et al. 2002; Lensjø et al. 2017; 
Rowlands et al. 2018), and in other brain areas (Fawcett et al. 2019; Reichelt et al. 
2019). PNNs are specialized extracellular matrix structures predominantly associated 
with PV interneurons in the visual cortex. They have essentially two structural roles: 
acting as scaffold for plasticity regulating the binding of molecules such as Otx2 
(Spatazza et al. 2013; Beurdeley et al. 2012) and Sema3a (Boggio et al. 2019), and 
limiting new synaptic connections (Faini et al. 2018). Adult mice treated with amiR-29a 
strongly upregulate extracellular matrix remodelers like MMP2, MMP13, and MMP9 
and reduce PNNs intensity and density,  while young animals treated with miR-29a 
mimic show a premature increase of PNNs intensity. Mir-29a also regulated the age-
related change in chemical composition of PNNs. Downregulation of miR-29a in adult 
mice causes a reduction of sulfonation of chondroitin sulfate in position 4 (C4S), a 
chemical modification of CSPGs typically enriched in adult brain and associated with 
reduced axon growth, regeneration and OD plasticity in the visual cortex (Yang et al. 
2017; Miyata et al. 2012; Foscarin et al. 2017).  This decrease is accompanied by 
upregulation of the miR-29a target ArsB (Bhattacharyya et al. 2015), the enzyme 
responsible to remove sulfate groups from C4S. Overall, these data indicate that miR-
29a coordinates the age-dependent regulation of several molecular pathways 
regulating CP plasticity. 
 




Importantly, miR-29a expression is not regulated by visual experience, suggesting that 
miR-29a mediate exclusively the action of age on CP timing. This information must be 
integrated with experience dependent signals unrelated to miR-29a, such as NARP 
and BDNF (Huang et al. 1999; Gu et al. 2013), to achieve input specific plasticity and 
experience-dependent regulation of CP timing. Mir-29a could act on CP timing also 
interacting with circadian clock mechanisms. Indeed previous work showed that clock 
mutation in PV cells causes an altered CP (Kobayashi et al. 2015), and miR-29a has 
been shown to affect circadian rhythmicity period through regulation of Per1 and 2 
mRNA stability and translation (Chen et al. 2013). 
Although mir-29a is broadly expressed in different cell types in the visual cortex, 
several data indicate that miR29a is a powerful molecular regulator of PV cell 
maturation. Our in situ hybridization and previous data obtained with Ago-CLIP (He et 
al. 2012)  showed that PV cells express high levels of miR-29a. Furthermore, the time 
course of cortical miR-29a expression is correlated with the maturation of WFA positive 
PNNs enwrapping PV cells. Moreover, mimicking or antagonizing miR-29a 
correspondingly modulated PV cell PNNs. PV levels were also downregulated by miR-
29a antagonization in adult animals, and bioinformatic analysis of proteomic data 
showed that PV cells represent the most affected cell population in terms of protein 
downregulation after amiR-29a treatment. Thus, PV cells could be preferential miR-
29a targets mediating miR-29a action on CP timing. 
Our results showing that miR-29a is a strong remodeler of PNNs open a therapeutic 
perspective for miR-29a and other miR-29 family members. Indeed, manipulations of 
PNNs, both PNN increases or decreases depending on the type of pathological 
condition, have been proposed for several diseases including schizophrenia, autism, 
addiction and seizures (Wen et al. 2018; Pantazopoulos and Berretta 2016; Sorg et al. 
2016). For example, preclinical studies and the analysis of human post-mortem 
samples of schizophrenic patients showing reductions of aggrecan and WFA staining 
indicated that PNN alterations could be a key component of the physiopathology of 
psychiatric disorders (Pantazopoulos et al. 2015; Pantazopoulos et al. 2010). On the 
other hand, several works have demonstrated that reduction of PNNs can be used to 
promote plasticity during aging and recovery from brain lesions  (Soleman et al. 2012; 
Gherardini et al. 2015; Hill et al. 2012; Wiersma et al. 2017; Fawcett et al. 2019). 
 




Moreover, the miR-29 family is acutely neuroprotective in stroke models (Ouyang et 
al. 2013; Khanna et al. 2013; Kobayashi et al. 2019). Considering that antimirs and 
miRNA mimics are under clinical trials for different human pathological conditions  
(Rupaimoole and Slack 2017), modulation of miR-29 family levels could be a concrete 

















































































Figure 1: miR-29a age-dependent regulation coordinates expression of extracellular and epigenetic
remodelling factors.
Venn diagram showing the intersection between putative miR-29a target genes and a) age-downregulated
genes, and b) upregulated genes. c) DAVID functional annotation clustering analysis showing the most
significant enriched pathways of putative targets enriched in downregulated genes. d) Mature miR-29a and
e) Dnmt3a expression level (normalized to P10) at different ages. f) Scatter plot showing that miR-29a and
Dnmt3a levels in the visual cortex display a strong negative correlation. Each circle represents data from a
single animal. g) Representative example of in situ hybridization on visual cortex (left P25, right P120) using
a LNA probe against miR-29a. Calibration bar 150 µm. h) Example of co-staining for PV (green), miR29
(red) and nuclear marker (blue). Calibration bar 15 µm. Error bars represent ±SEM. Asterisk statistical
significance.
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Figure 2: miR-29a expression is not
experience-dependent.
Mature miR-29a levels were not affected by
dark rearing a) from birth (DRb) and b) from
P10 (DRp10) with respect to normal rearing
mice (NR). Analysis was performed at P25.
c) Mature miR-29a levels were not affected
by a one week period of dark rearing
beginning at P30 (DRw) and by a
subsequent exposure to light (DRw+4h)
compared to NR mice. d) MD did not affect
miR-29a expression in the visual cortex
contralateral (contra ctx) to the deprived eye
with respect to the ipsilateral cortex (ipsi ctx).
Error bars represent ±SEM. Asterisk
statistical significance.
Fig.3
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Figure 3: miR-29a upregulation blocks OD plasticity of young mice.
a) Experimental design for miR-29a mimic treatment in young mice. b) MiR-29a and c) Dnmt3a expression
in the cortex treated with scrambled or miR-29a mimic. Data were normalized to the untreated cortex of the
same animal. d) IOS analysis. Ocular dominance index (ODI) of deprived animals treated with scrambled
(scr, black lines) and miR-29a mimic (mim29a, orange lines) before and after 3 days of MD. Dashed lines
represent single animals, continuous lines the group average. e) The effects of MD on expression of Npas
IV and Bdnf exIV is reported as ratio between expression level of deprived and nondeprived cortex for
animals treated with scrambled (scr+MD) and miR-29a mimic (mim29a+MD). Each symbol represents the
























































Figure 4: Transcriptomic and proteomic effects of miR-29a downregulation.
a) Experimental design for antimir-29a treatment in adult mice. b) MiR-29a and c) Dnmt3a expression are
dramatically affected by amiR-29a. Fold change values with respect to the contralateral untreated cortex are
reported for mice treated with amiR-29a or scrambled (scr). d) Volcano plot of RNA-seq analysis showing
for each differentially expressed gene (scr versus amiR29a) the relationship between its fold change and
statistical significance comparing the scr and amiR-29a treated cortex. Black circles represents putative
targets of miR-29. e) Scatter plot correlating the expression changes induced by miR-29a antagonization in
adult mice at proteomic and transcriptomic levels. Black line is the linear regression with 95% confidence
band. f) DAVID functional annotation clustering analysis showing the most significant enriched pathways of
genes and proteins positivity correlated. Error bars represent ±SEM. Asterisk statistical significance,
**p<0.01 ****p<0.0001. g) RT-PCR analysis of the expression of extracellular matrix remodellers
(MMP2,MMP9,MMP13) and h) epigenetic factors (Dnmt3a, Tet3, Gadd45a, Gadd45b) in animals treated
with amiR-29a with respect to control animals treated with scrambled LNA (scr). Data for scr and amiR-29
treated cortices are normalized to the contralateral untreated cortex of the same animal. i) Dnmt3a
upregulation is confirmed also by western blot analysis of visual cortex. Left: example of Dnmt3a western
blot. The lanes corrisponding to the treated (treat scr or treat amiR-29a) and untreated (untreat scr or
untreat amiR-29a) cortex (ctx) of two amiR-29a treated and two scr treated mice are reported. Right:
quantification of the data shows Dnmt3a upregulation by amiR29a. The results are expressed as fold
change normalized to untreated cortex. Each symbol represent the result of one animal. Error bars
represent ±SEM. Asterisk statistical significance, **p<0.01, ***p<0.0001 ****p<0.0001.
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Figure 5: miR-29a downregulation restores experience-dependent plasticity in adult mice with
similar physiological and proteomics features of juvenile mice.
a) VEPs analysis. Ratio between contralateral and ipsilateral eye responses (C/I ratio) in animal treated with
saline and not deprived (sal no MD), with scrambled LNA and deprivation (scr MD), with antimir-29a LNA
and deprivation (amiR29a MD). b) IOS analysis. ODI of deprived animals treated with scrambled (black
lines) and antimiR-29a LNA (blue lines). Dashed lines connect pre- and post-MD ODI values of each
animal. Full lines represent the group average. c) IOS amplitude in response to contralateral eye (contra)
and ipsilateral eye (ipsi) stimulation. Other conventions as in b. d) Average time course of the IOS response
to visual stimulation of the contralateral eye (contra) pre- and post-MD. Grey traces are scrambled animals;
blue traces are amiR-29a animals. e) Same as in d for ipsilateral eye (ipsi) pre- and post-MD responses. (f)
The effects of MD on Npas IV and Bdnf exIV expression is reported as the ratio between expression levels
of deprived and nondeprived cortex for animals treated with scrambled (scr+MD) and amiR-29a (amiR-
29a+MD). Each symbol represent the result of one animal. Error bars represent ±SEM. Asterisk statistical
significance, **p<0.01, ***p<0.0001 ****p<0.0001. g) Scatter plot correlating the expression changes
induced by MD in young mice (MD CP, x-axis) with the effects observed in the adult deprived mice treated
with amiR-29a (amiR29a MD AD, y-axis). Proteins present in both data sets and showing an expression fold
change (FC>0.1) are reported. Green symbols represent positively correlated proteins; red symbols report
anticorrelated proteins. h) Reactome analysis of positively correlated proteins showing enrichment in gene
categories related to synaptic plasticity. For each category the fold enrichment in positively correlated
proteins is reported as function of statistical significance (-log10 FDR of differentially expression). c)
Hierchical dendrograms of synaptic proteins (synGO database) showing significant enrichment by colour-
code. Several highly significant categories are present for positively correlated proteins. i) A weak
significance only for the general “synaptic proteins” categories is present the anticorrelated protein set.
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Figure 6: Manipulations of miR-29aa levels promote changes in PNNs
a) Images of WFA-labeled PNNs of scrambled treated visual cortex (top) and miR-29a mimic (bottom) in
young mice. Calibration bar 60 µm. b) Quantification of PNN intensity and c) density for each animal. d)
Cumulative frequency of PNNs intensity in scrambled and mimic treated young mice expressed as
cumulative frequency. e) PNN distribution in classes of intensity in mice treated with scrambled and mimic
29a.f) Images of WFA-labeled PNNs of scrambled treated visual cortex (top) and amiR-29a LNA (bottom)
in adult mice. Calibration bar 60 µm. g) Quantification of PNN intensity and h) density for each animal. i)
Cumulative frequency of PNNs intensity in scrambled and amiR29a treated adult mice. j) PNN distribution
in classes of intensity in mice treated with scrambled and amiR29a. k) Biochemical quantification of C4S in
adult amiR-29a treated mice as compared to scrambled animals. l) Example of Arylsulfatase B (ArsB)
western blot. Top: The lanes corrisponding to the treated (treat scr or treat amiR-29a) and untreated
(untreat scr or untreat amiR-29a) cortex (ctx) of two amiR-29a treated and two scr treated mice are
reported. Bottom: quantification of the data shows ArsB upregulation by amiR29a. The results are
expressed as fold change normalized to untreated cortex. Each symbol represent the result of one animal.
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Suppl Figure 1: Proteomic modulations
induced by miR-29a downregulation.
Hierarchical clustering graph of proteomic results
showed that animals treated with amiR-29a LNA

















Suppl. Figure 2: Single cells analysis.
a) Single-cell clusters of genes expressed in adult visual cortex from Tasic et al 2016. b) In silico single cell
analysis of amiR-29a upregulated and c) downregulated proteins. The most affected cell populations are,
respectively, mature oligodendrocytes and “GABA parvalbumin” cluster cells. d) Examples of PV
immunostaining in adult mice treated with scrambled (right) and amiR-29a LNA (left). Calibration bar 100
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